News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Jay Bradner: I am overjoyed by the opportunity to create and develop therapeutic solutions for patients
Photo taken from Jay Bradner/LinkedIn
Dec 20, 2023, 18:43

Jay Bradner: I am overjoyed by the opportunity to create and develop therapeutic solutions for patients

Jay Bradner, Executive Vice President of R&D, and Chief Scientific Officer at Amgen shared on LinkedIn:

“Bob Bradway today announced that I have joined his leadership team as Executive Vice President of R&D, and Chief Scientific Officer. I am overjoyed by the opportunity to create and develop therapeutic solutions for patients with serious illnesses and to work alongside such wonderful people. Here are some additional reflections.”

For details click here.
Source: Jay Bradner/LinkedIn

Bob Bradway cancer Chief Scientific Officer Executive Vice President Jay Bradner leadership team OncoDaily Oncology
Special Coverage
Blog
May 16, 2025, 17:22
APHINITY Trial Update Shows OS Benefit with Pertuzumab in HER2+ Breast Cancer - ESMO
Blog
May 16, 2025, 17:20
Two Studies Presented at ESMO Breast 25 Highlight the Potential Benefits of Tailoring Chemotherapy
Blog
May 16, 2025, 17:04
Elia Seguí: Happy to have presented today at ESMO Breast 2025 our work on TLS in breast cancer
Blog
May 16, 2025, 16:52
ECOG-ACRIN Cancer Research Group Announces Spring 2025 Edith Peterson Mitchell Health Equity Scholarship Recipients
Blog
May 16, 2025, 16:47
Erin Polak: Barriers to Early Cancer Detection at ACS CAN National Forum
Science
May 16, 2025, 16:46
David R. Liu: A Medical Milestone in Patient-Specific Gene Editing - From design to dosing in 7 months
Blog
May 16, 2025, 16:35
Roberto Sabatini and Young Researchers Honored with Meet-URO Awards 2025
Blog
May 16, 2025, 16:32
Saddened to Share the Passing of Associate Professor Josh McCarroll - Children's Cancer Institute
Insight
May 16, 2025, 16:21
Amar Kishan: Proud to Share Outcomes for phase II SCIMITAR Trial Published in JAMA Oncology
Science
May 16, 2025, 16:18
Myeloma Paper of the Day, May 16th, suggested by Robert Orlowski
Insight
May 16, 2025, 16:03
START Doses 1st US Patient in Moderna's Pan-Tumor Antigen Therapy Study in Solid Tumors
Blog
May 16, 2025, 15:51
Myeloma Society Call for Abstracts for the 22nd International Myeloma Society Annual Meeting